4.6 Article

Vagus nerve stimulation for treating developmental and epileptic encephalopathy in young children

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Physiology

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES: FROM GENETIC HETEROGENEITY TO PHENOTYPIC CONTINUUM

Renzo Guerrini et al.

Summary: Developmental and epileptic encephalopathies (DEEs) are a group of disorders characterized by early-onset severe epileptic seizures, EEG abnormalities, and developmental impairment. DEEs can be caused by genetic and nongenetic factors, with mutations in various genes playing a role. Research in animal models and clinical trials have helped uncover the pathophysiological mechanisms underlying DEEs and explore different treatment options.

PHYSIOLOGICAL REVIEWS (2023)

Review Clinical Neurology

The epilepsy-autism spectrum disorder phenotype in the era of molecular genetics and precision therapy

Nicola Specchio et al.

Summary: Early interventions targeting social and cognitive deficits can have positive effects on the developmental outcome of infants with epilepsy and autism spectrum disorder (ASD). The complexity of early diagnosis in these cases is influenced by variability in clinical phenotypes. Common biological and molecular mechanisms have been suggested, with a genetic focus on abnormalities in synaptic growth, neuron excitation/inhibition balance, and synaptic plasticity.

EPILEPSIA (2022)

Article Behavioral Sciences

Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex

Xuezhi Tong et al.

Summary: This study shows that Vagus Nerve Stimulation (VNS) is a safe and effective treatment for drug-resistant epilepsy (DRE) induced by tuberous sclerosis complex (TSC), and it may improve cognitive and emotional states in patients. Further investigations are needed to validate the results.

EPILEPSY & BEHAVIOR (2022)

Review Medicine, Research & Experimental

Effect of Vagus Nerve Stimulation on Attention and Working Memory in Neuropsychiatric Disorders: A Systematic Review

Daruj Aniwattanapong et al.

Summary: This study conducted a systematic review on the effects of VNS on attention and working memory in patients with neuropsychiatric disorders. The results showed that although there were some positive results, there is currently insufficient high-quality evidence to support VNS as an effective intervention for enhancing attention and working memory in individuals with neuropsychiatric disorders.

NEUROMODULATION (2022)

Article Pharmacology & Pharmacy

Efficacy and potential predictors of vagus nerve stimulation therapy in refractory postencephalitic epilepsy

Siqi Liu et al.

Summary: Background: Vagus nerve stimulation (VNS) is an effective palliative therapy for patients with refractory postencephalitic epilepsy (PEE). Preoperative predictors of VNS effectiveness include high seizure frequency and focal interictal epileptic discharges (IEDs).

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2022)

Article Clinical Neurology

ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions

Sameer M. Zuberi et al.

Summary: This article proposes a classification and definition of epilepsy syndromes in neonates and infants, aiming to support epilepsy diagnosis and emphasize the importance of classifying epilepsy by syndrome and etiology. The article reports the epidemiology, clinical course, seizure types, EEG, neuroimaging, genetics, and differential diagnosis for each syndrome, and presents self-limited syndromes, developmental and epileptic encephalopathies, and etiology-specific epilepsy syndromes.

EPILEPSIA (2022)

Article Clinical Neurology

Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions

Elaine C. Wirrell et al.

Summary: This paper describes the process of reaching consensus on the classification and definition of epilepsy syndromes by the International League Against Epilepsy (ILAE), as well as providing clinical data templates for each syndrome. The diagnosis of an epilepsy syndrome carries significant implications for prognosis and treatment, and these syndromes often present with age-dependent characteristics and comorbidities.

EPILEPSIA (2022)

Article Clinical Neurology

Phenotypic spectrum and long-term outcome of children with genetic early-infantile-onset developmental and epileptic encephalopathy

Chunhui Hu et al.

Summary: This study identified various genetic mutations in children with early-infantile-onset DEE, showing diverse responses to antiseizure medications. Specific medications were found to have good therapeutic effects in patients with specific gene variants.

EPILEPTIC DISORDERS (2022)

Review Clinical Neurology

The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis

Sabastian Hajtovic et al.

Summary: The authors conducted a systematic review on the effectiveness of VNS in children with genetic etiologies of epilepsy. Among the most studied conditions, patients with TSC showed substantial seizure reduction and improvements in QOL, while those with DS had less robust results.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2022)

Review Medicine, Research & Experimental

Short- and Long-Term Response of Vagus Nerve Stimulation Therapy in Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis

Hongliang Mao et al.

Summary: A total of 61 studies with 5223 patients were included in the study. The short-term responder rates for VNS therapy were high, with low overall incidences of complications such as hoarseness/voice change, throat pain, coughing, dyspnea, paresthesia, muscle pain, and headache. VNS therapy was shown to be a safe and effective treatment option for patients with DRE.

NEUROMODULATION (2022)

Article Clinical Neurology

Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood

Hannah Stamberger et al.

Summary: This study investigates the natural history of STXBP1-DEE in adults and reveals that seizures, movement disorders, and functional dependence are still present in adult patients. Understanding the natural history of STXBP1-DEE is crucial for prognosis and future therapeutic trials.

NEUROLOGY (2022)

Article Clinical Neurology

Vagus nerve stimulation for refractory posttraumatic epilepsy: Efficacy and predictors of seizure outcome

Mengyi Guo et al.

Summary: The study retrospectively collected the outcomes of VNS treatment in patients with refractory PTE, with at least a 1-year follow-up. The responder rate increased over time, and patients with focal or multifocal interictal epileptic discharges were found to have better efficacy after VNS therapy.

FRONTIERS IN NEUROLOGY (2022)

Article Clinical Neurology

Vagus nerve stimulation in children with drug-resistant epilepsy of monogenic etiology

Han Xie et al.

Summary: Vagus nerve stimulation (VNS) is an effective treatment for pediatric patients with drug-resistant epilepsy (DRE) of monogenic etiology. However, it is uncertain whether patients with rare variants of epilepsy-related genes can benefit from this treatment.

FRONTIERS IN NEUROLOGY (2022)

Review Endocrinology & Metabolism

Therapeutic applications of transcutaneous auricular vagus nerve stimulation with potential for application in neurodevelopmental or other pediatric disorders

Siyu Zhu et al.

Summary: This review discusses the potential therapeutic use of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) in pediatric neurodevelopmental and psychiatric disorders, based on current literature. The review also briefly explores factors that could optimize taVNS protocols in future clinical applications.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Medicine, General & Internal

Vagus nerve stimulation outcome prediction: from simple parameters to advanced models

Chrastina Jan et al.

Summary: This study provides an overview of the potential predictors of VNS response, ranging from simple data to sophisticated EEG processing studies and functional imaging. The results support better outcomes in specific types of patients.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2022)

Review Clinical Neurology

Vagus nerve stimulation for treatment of drug-resistant epilepsy: a systematic review and meta-analysis

Lim Mervyn Jun Rui et al.

Summary: Through data analysis from randomized controlled trials, it was found that high-frequency VNS can reduce seizure frequency and improve treatment response in patients with drug-resistant epilepsy compared to control groups. Greater consideration should be given to using VNS in the management of these patients to decrease seizure frequency.

NEUROSURGICAL REVIEW (2022)

Article Clinical Neurology

Subgroup analysis of seizure and cognitive outcome after vagal nerve stimulator implantation in children

Corine Knorr et al.

Summary: Early VNS implantation in children with epilepsy may lead to improved quality of life and cognitive outcomes. Patients with epilepsy due to encephalitis showed higher rates of seizure reduction after VNS implantation, but also higher complication rates. Additionally, shorter duration of preoperative seizures and higher preoperative seizure frequency may be associated with better developmental and quality of life outcomes.

CHILDS NERVOUS SYSTEM (2021)

Article Clinical Neurology

Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: A meta-analysis

Maxine Dibue et al.

Summary: The meta-analysis of 480 patients with LGS revealed that 54% of patients responded to adjunctive VNS Therapy, which was found to be safe and well-tolerated. An exploratory analysis showed a 9% incidence of serious adverse events associated with VNS Therapy.

ACTA NEUROLOGICA SCANDINAVICA (2021)

Editorial Material Clinical Neurology

Developmental and epileptic encephalopathies: what we do and do not know

Nicola Specchio et al.

Summary: Developmental encephalopathies, including intellectual disability and autistic spectrum disorder, are often associated with infant epilepsy. Epileptic encephalopathy is used to describe a presumed causal relationship between epilepsy and developmental delay. The development of developmental and epileptic encephalopathies may continue even when seizures are controlled, indicating a more complex relationship between these conditions.
Article Clinical Neurology

The severe epilepsy syndromes of infancy: A population-based study

Katherine B. Howell et al.

Summary: The study found that West syndrome and West syndrome-like epilepsy are the most common epilepsy syndromes among severe epilepsies of infancy, while the incidence of epilepsy of infancy and early infantile epileptic encephalopathy is lower. Most infants showed delayed or borderline development before the age of 2, with a small percentage of infants dying before the age of 2.

EPILEPSIA (2021)

Review Clinical Neurology

Early-Onset Developmental and Epileptic Encephalopathies of Infancy: An Overview of the Genetic Basis and Clinical Features

Nadine Morrison-Levy et al.

Summary: Our understanding of genetically determined types of epilepsy has shortened the usual diagnostic pathway for families of infants with early-onset developmental and epileptic encephalopathies. Up to 80% of infants with early-onset developmental and epileptic encephalopathies may have genetic causes. A genetic diagnosis can lead to early therapeutic intervention and the use of new treatment methods.

PEDIATRIC NEUROLOGY (2021)

Review Clinical Neurology

SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis

Jiangwei Ding et al.

Summary: SCN1A mutations are not only associated with Dravet syndrome, but also with various other epileptic encephalopathies and related disorders.

FRONTIERS IN NEUROLOGY (2021)

Review Clinical Neurology

Is vagal-nerve stimulation safe during pregnancy? A mini review

Jiangwei Ding et al.

Summary: Vagus-nerve stimulation (VNS) may have little effect on pregnancy, with research indicating that it can be relatively safe and effective for both the fetus and mother during pregnancy. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these findings.

EPILEPSY RESEARCH (2021)

Article Clinical Neurology

Developmental and epileptic encephalopathies: recognition and approaches to care

Sharika Raga et al.

Summary: DEE encompasses cognitive functions affected by both seizures and interictal epileptiform activity, requiring precision therapies tailored to individual needs. DE and EE categorize different diseases with distinct cognitive states, with DE requiring attention to other treatment aspects and EE needing aggressive intervention to help patients revert to normal cognitive states.

EPILEPTIC DISORDERS (2021)

Review Neurosciences

Why we urgently need improved seizure and epilepsy therapies for children and neonates

Ronit M. Pressler et al.

NEUROPHARMACOLOGY (2020)

Review Clinical Neurology

A 2020 View on the Genetics of Developmental and Epileptic Encephalopathies

Hannah C. Happ et al.

EPILEPSY CURRENTS (2020)

Article Behavioral Sciences

Vagus nerve stimulation in patients with therapy-resistant generalized epilepsy

Ana Suller Marti et al.

EPILEPSY & BEHAVIOR (2020)

Review Clinical Neurology

Vagus nerve stimulation for drug-resistant epilepsy

Laura Perez-Carbonell et al.

PRACTICAL NEUROLOGY (2020)

Review Genetics & Heredity

Epilepsy genetics: Current knowledge, applications, and future directions

K. A. Myers et al.

CLINICAL GENETICS (2019)

Article Genetics & Heredity

Clinical and genetic spectrum of a large cohort of children with epilepsy in China

Lin Yang et al.

GENETICS IN MEDICINE (2019)

Article Clinical Neurology

Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy

Hai-Jiao Wang et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)

Article Clinical Neurology

Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study

Jan Chrastina et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)

Article Multidisciplinary Sciences

Neuronal Networks during Burst Suppression as Revealed by Source Analysis

Natia Japaridze et al.

PLOS ONE (2015)

Article Clinical Neurology

Predictors of Response to Vagus Nerve Stimulation in Childhood-Onset Medically Refractory Epilepsy

Ravindra Arya et al.

JOURNAL OF CHILD NEUROLOGY (2014)

Review Biochemistry & Molecular Biology

The chemical neuroanatomy of vagus nerve stimulation

Riccardo Ruffoli et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2011)

Article Clinical Neurology

Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response A review

Dario J. Englot et al.

JOURNAL OF NEUROSURGERY (2011)